◆ NeutralMMTC

Micro Imaging Technology is pleased to Announce the Acquisition of Cellmyx

Benzinga·
Micro Imaging Technology is pleased to Announce the Acquisition of Cellmyx

Micro Imaging Technology, Inc. (MMTC) announced the acquisition of Cellmyx, a 25-year-old manufacturer of medical tools for aesthetic, cosmetic surgery, and regenerative medicine. The acquisition complements MIT's previous acquisition of SaltMed/SaltFacial and strengthens the company's ability to expand and manufacture products nationally and worldwide. Cellmyx specializes in autologous adipose grafting and holds FDA clearance for its intelliFat® BOD™ technology for orthopedic and cosmetic procedures.

Read Full Article at Benzinga
← Back to Financial Intelligence